BVMF/N1VO34 (BVMF/N1VO34)

Brazil Stock Exchange: BVMF/N1VO34 · BRL

R$25.4

-0.31 (-1.2%)· Recorded snapshot

Market cap	903.8B
Revenue (ttm)	260.8B
Net income (ttm)	92.2B
EPS (ttm)	R$2.61
P/E (trailing)	9.7x
P/E (forward)	11.5x
Dividend	R$0.77 (3.02%)
Volume	47,203
Beta	0.38

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 260.8B
Net income (ttm): 92.2B
EPS (ttm): R$2.61
P/E (trailing): 9.7x
P/E (forward): 11.5x
Market cap: 903.8B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E11.5

P25 n/aP50 n/aP75 n/a

Trailing P/E9.7

P25 n/aP50 n/aP75 n/a

ROE59.8

P25 n/aP50 n/aP75 n/a

ROIC39.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/N1VO34 indicators

Market & fundamental data

Available fields

245

Groups with data

Currency

DKK

Showing 245 of 245 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	Denmark
Country code	BR
Earnings date	2026-11-04
Employees	66,700
Employees change	-7,844
Employees growth	-10.14%
Enterprise value	BRL 980.1B
Exchange	Brazil Stock Exchange
Financial currency	DKK
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1923
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	BRN1VOBDR005
Last earnings date	2026-08-05
Last refreshed	2026-10-29
Last stock split date	2023-09-20
Last stock split type	Forward
Market cap	BRL 903.8B
Next earnings date	2026-11-04
Price	BRL 25.44
Price currency	BRL
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	bvmf/N1VO34
Website	https://www.novonordisk.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	25.52x
Average P/E ratio (3Y)	26.67x
Average P/E ratio (5Y)	30.16x
Earnings yield	10.26%
EV/Earnings	10.63x
EV/EBIT	7.58x
EV/EBITDA	6.98x
EV/FCF	16.32x
EV/Sales	3.71x
FCF / EV yield	6.13%
FCF yield	6.64%
Forward P/E	11.47x
Graham number	17.01343
Graham upside	-33.31%
Lynch fair value	BRL 55.39
Lynch upside	117.13%
P/(FCF - SBC) ratio	15.34x
P/(OCF - SBC) ratio	8.75x
P/B ratio	5.16x
P/E ratio	9.75x
P/FCF ratio	15.05x
P/OCF ratio	8.66x
P/S ratio	3.47x
Price / tangible book value	11.51x
Price/EBITDA ratio	6.57x
Sector forward P/E	11.05x
Sector P/E	41.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	48.99%
EBITDA margin	52.72%
Effective tax rate	21.72%
FCF margin	22.87%
Gross margin	81.99%
Operating margin	48.99%
Pretax margin	45.15%
Profit margin	35.35%
Profit per employee	BRL 1.4M
Profitable quarters	164
Profitable years	41
Revenue per employee	BRL 3.9M
ROA	18.73%
ROA (5Y)	21.35%
ROCE	45.35%
ROE	59.82%
ROE (5Y)	74.56%
ROIC	39.22%
ROIC (5Y)	68.16%
SBC / revenue	0.44%
Tax / revenue	9.81%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	4.98%
EPS growth (Q)	-20.61%
EPS growth (QoQ)	-56.63%
EPS growth 10Y	14.01%
EPS growth 3Y	20.74%
EPS growth 5Y	22.33%
EPS growth years	31
FCF growth	14.3%
FCF growth (Q)	56.84%
FCF growth (QoQ)	232.92%
FCF growth 3Y	2.24%
FCF growth 5Y	9.51%
Gross profit growth	2.76%
Gross profit growth (Q)	-4.1%
Gross profit growth 3Y	16.73%
Gross profit growth 5Y	20.17%
Net income growth	4.84%
Net income growth (Q)	-20.81%
Net income growth (QoQ)	-56.77%
Net income growth 3Y	20.09%
Net income growth 5Y	21.29%
Net income growth years	38
OCF growth	7.52%
OCF growth (Q)	32.14%
OCF growth (QoQ)	129.19%
OCF growth 10Y	11.56%
OCF growth 3Y	13.7%
OCF growth 5Y	19.47%
Operating income growth	9.29%
Operating income growth (Q)	-0.18%
Operating income growth 3Y	22.91%
Operating income growth 5Y	24.43%
Revenue growth	5.61%
Revenue growth (Q)	2.12%
Revenue growth (QoQ)	-18.94%
Revenue growth 10Y	11.56%
Revenue growth 3Y	17.84%
Revenue growth 5Y	20.45%
Revenue growth quarters	2
Revenue growth years	8

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -44.4B
Depreciation and amortization	BRL 9.8B
EBIT	BRL 127.8B
EBITDA	BRL 137.5B
EPS	BRL 2.61
Financing cash flow	BRL -17.6B
Free cash flow	BRL 60B
Free cash flow minus SBC	BRL 58.9B
Gross profit	BRL 213.8B
Income taxes	BRL 25.6B
Investing cash flow	BRL -66.1B
Net borrowing	BRL 29B
Net cash flow	BRL 20.6B
Net income	BRL 92.2B
Operating cash flow minus SBC	BRL 103.3B
Operating income	BRL 127.8B
Revenue	BRL 260.8B
Stock-based compensation	BRL 1.1B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.21
Book value per share	BRL 39.56
Debt / EBITDA	0.8
Debt / equity	0.63
Debt / FCF	1.85
Goodwill	BRL 15.9B
Interest coverage	1,566.84
Long-term assets	BRL 304.7B
Long-term liabilities	BRL 105.3B
Net cash (debt)	BRL -75.3B
Net cash / market cap	-8.33%
Net debt / EBITDA	0.55
Net debt / equity	0.43
Net debt / FCF	1.25
Piotroski F-Score	5
Property, plant and equipment	BRL 184.7B
Shareholders' equity	BRL 175.2B
Tangible book value	BRL 78.6B
Tangible book value per share	BRL 17.74
Total assets	BRL 471B
Total cash	BRL 35.6B
Total debt	BRL 110.9B
Total liabilities	BRL 295.8B
WACC	5.67%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.61
Current assets	BRL 166.3B
Current liabilities	BRL 190.6B
Current ratio	0.87
Inventory turnover	1.22
Net working capital	BRL -45.2B
Quick ratio	0.64
Working capital	BRL -24.1B
Working capital turnover	-6.94

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.14%
Dividend growth	-5.66%
Dividend growth (3Y)	18.12%
Dividend growth years	3
Dividend payment date	2026-08-31
Dividend payment years	5
Dividend payout frequency	Semi-Annual
Dividend per share	BRL 0.77
Dividend yield	3.02%
Ex-dividend date	2026-08-14
Last dividend	BRL 0.31
Payout ratio	44.64%
Shareholder yield	3.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 27.82
1D price change	-1.2%
1M price change	0.04%
1M total return	0.04%
1W price change	3.25%
1W total return	3.25%
1Y price change	-28.54%
1Y return CAGR	-26.28%
1Y total return	-26.27%
20-day SMA	BRL 24.48
200-day SMA	BRL 28.69
3M price change	-19.24%
3M total return	-18.54%
3Y price change	-56.47%
3Y return CAGR	-22.71%
3Y total return	-53.83%
50-day SMA	BRL 26.77
50-day SMA vs 200-day SMA	50under200
52-week high	BRL 42.43
52-week high date	2026-01-23
52-week low	BRL 22.90
52-week low date	2026-03-30
6M price change	-0.27%
6M total return	0.59%
All-time high	BRL 103.10
All-time high date	2024-07-01
All-time low	BRL 22.90
All-time low date	2026-03-30
Average true range (ATR)	BRL 0.75
Average volume	22.2K
Beta (5Y)	0.38
Change from 52-week high	-40.04%
Change from 52-week low	11.09%
Change from all-time high	-75.32%
Change from all-time low	11.09%
Change from open	-0.04%
Day's gap	-1.17%
Dollar volume	BRL 1.2M
High price	BRL 25.77
Low price	BRL 25.31
Monthly RSI	36.82
Open price	BRL 25.45
Position in 52-week range	28.26%
Previous close	BRL 25.75
Price vs 150-day SMA	-8.56%
Price vs 20-day SMA	3.92%
Price vs 200-day SMA	-11.32%
Price vs 50-day SMA	-4.95%
Relative volume	2.13
RSI	51.02
Sharpe ratio	-0.51
Sharpe ratio (3Y)	-0.48
Sortino ratio	-0.55
Sortino ratio (3Y)	-0.51
Volume	47.2K
Weekly RSI	40.98
YTD price change	-29.29%
YTD total return	-27.05%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3.2B
Shares change (QoQ)	-0.29%
Shares change (YoY)	-0.14%
Shares held by insiders	0.02%
Shares held by institutions	27.52%

Deeper analysis on BVMF/N1VO34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/N1VO34 report

Is a complete BVMF/N1VO34 research report available?

No complete published report is available for bvmf/N1VO34 (BVMF/N1VO34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/N1VO34 (BVMF/N1VO34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/N1VO34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/N1VO34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/N1VO34

Frequently asked questions